Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways

被引:257
作者
Ramana, CV
Grammatikakis, N
Chernov, M
Nguyen, H
Goh, KC
Williams, BRG
Stark, GR
机构
[1] Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA
[3] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA
关键词
c-jun; cell proliferation; geldanamycin; p50(cdc37); PKR;
D O I
10.1093/emboj/19.2.263
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferons (IFNs) inhibit cell growth in a Stat1-dependent fashion that involves regulation of c-my expression. IFN-gamma suppresses c-myc in wild-type mouse embryo fibroblasts, but not in Stat1-null cells, where IFNs induce c-myc mRNA rapidly and transiently, thus revealing a novel signaling pathway, Both tyrosine and serine phosphorylation of Stat1 are required for suppression. Induced expression of c-myc is likely to contribute to the proliferation of Stat1-null cells in response to IFNs, IFNs also suppress platelet-derived growth factor (PDGF)-induced c-myc expression in wild-type but not in Stat1-null cells. A gamma-activated sequence element in the promoter is necessary but not sufficient to suppress c-myc expression in wild-type cells. In PKR-null cells, the phosphorylation of Stat1 on Ser727 and transactivation are both defective, and c-myc mRNA is induced, not suppressed, in response to IFN-gamma. A role for Raf-l in the Stat1-independent pathway is revealed by studies with geldanamycin, an HSP90-specific inhibitor, and by expression of a mutant of p50(cdc37) that is unable to recruit HSP90 to the Raf-1 complex. Both agents abrogated the IFN-gamma-dependent induction of c-myc expression in Stat1-null cells.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 86 条
  • [1] Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line
    Abril, E
    Real, LM
    Serrano, A
    Jimenez, P
    García, A
    Canton, J
    Trigo, I
    Garrido, F
    Ruiz-Cabello, F
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (02) : 113 - 120
  • [2] Aziz N, 1999, MOL CELL BIOL, V19, P1101
  • [3] INTERFERON AFFECTS BOTH G1 AND S+G2 IN CELLS STIMULATED FROM QUIESCENCE TO GROWTH
    BALKWILL, F
    TAYLORPAPADIMITRIOU, J
    [J]. NATURE, 1978, 274 (5673) : 798 - 800
  • [4] Bao JX, 1996, ONCOGENE, V12, P2171
  • [5] DEREGULATED EXPRESSION OF THE C-MYC ONCOGENE ABOLISHES INHIBITION OF PROLIFERATION OF RAT VASCULAR SMOOTH-MUSCLE CELLS BY SERUM REDUCTION, INTERFERON-GAMMA, HEPARIN, AND CYCLIC-NUCLEOTIDE ANALOGS AND INDUCES APOPTOSIS
    BENNETT, MR
    EVAN, GI
    NEWBY, AC
    [J]. CIRCULATION RESEARCH, 1994, 74 (03) : 525 - 536
  • [6] MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC
    BLACKWOOD, EM
    EISENMAN, RN
    [J]. SCIENCE, 1991, 251 (4998) : 1211 - 1217
  • [7] Control of cell proliferation by Myc
    Bouchard, C
    Staller, P
    Eilers, M
    [J]. TRENDS IN CELL BIOLOGY, 1998, 8 (05) : 202 - 206
  • [8] Bromberg JF, 1998, CELL GROWTH DIFFER, V9, P505
  • [9] Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma
    Bromberg, JF
    Horvath, CM
    Wen, ZL
    Schreiber, RD
    Darnell, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7673 - 7678
  • [10] CAUX C, 1992, BLOOD, V79, P2628